PLoS ONE (Jan 2017)

Early protection events in swine immunized with an experimental live attenuated classical swine fever marker vaccine, FlagT4G.

  • Lauren G Holinka,
  • Vivian O'Donnell,
  • Guillermo R Risatti,
  • Paul Azzinaro,
  • Jonathan Arzt,
  • Carolina Stenfeldt,
  • Lauro Velazquez-Salinas,
  • Jolene Carlson,
  • Douglas P Gladue,
  • Manuel V Borca

DOI
https://doi.org/10.1371/journal.pone.0177433
Journal volume & issue
Vol. 12, no. 5
p. e0177433

Abstract

Read online

Prophylactic vaccination using live attenuated classical swine fever (CSF) vaccines has been a very effective method to control the disease in endemic regions and during outbreaks in previously disease-free areas. These vaccines confer effective protection against the disease at early times post-vaccination although the mechanisms mediating the protection are poorly characterized. Here we present the events occurring after the administration of our in-house developed live attenuated marker vaccine, FlagT4Gv. We previously reported that FlagT4Gv intramuscular (IM) administered conferred effective protection against intranasal challenge with virulent CSFV (BICv) as early as 7 days post-vaccination. Here we report that FlagT4Gv is able to induce protection against disease as early as three days post-vaccination. Immunohistochemical testing of tissues from FlagT4Gv-inoculated animals showed that tonsils were colonized by the vaccine virus by day 3 post-inoculation. There was a complete absence of BICv in tonsils of FlagT4Gv-inoculated animals which had been intranasal (IN) challenged with BICv 3 days after FlagT4Gv infection, confirming that FlagT4Gv inoculation confers sterile immunity. Analysis of systemic levels of 19 different cytokines in vaccinated animals demonstrated an increase of IFN-α three days after FlagT4Gv inoculation compared with mock infected controls.